Aldeyra Therap
ALDX1.6000.62% ( -0.010 )
Aldeyra Therap (ALDX)
Aldeyra Therapeutics, Inc., a biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases. Its lead product candidate is...
- Open
- 1.630
- High
- 1.670
- Low
- 1.595
- Prev. Close
- 1.610
- Volume
- 548.89K
- Turnover
- 888.30K
- Avg Price
- 1.618
- Bid/Ask Ratio
- --
- Amplitude
- 4.66%
- 52wk High
- 6.175
- Volume Ratio
- 0.34
- Turnover Ratio
- 1.04%
Aldeyra Therap Analyst Rating
View MoreForecast & Rating
Jul 17, 2026Price forecast
$6.60312.50%
Forecast & RatingBuy
6analysts
- Strong buy66.67%
- Buy16.67%
- Hold16.67%
- Sell0.00%
- Strong sell0.00%
News
- Market Beat · 9 hours ago
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) Short Interest Update
- benzinga_article · 2 days ago, 07:05 AM
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- Global Report · Jul 21 at 04:13 AM
Capital Rotations: A Record Biotech IPO and the Surging European Defense ETF
- TradingView · Jul 15 at 03:53 PM
Aldeyra Therapeutics to seek Type D meeting with FDA on reproxalap NDA resubmission
- Simplywall · Jun 10 at 08:18 AM
Aldeyra Therapeutics CEO, President & Director Acquires 18% More Stock
- StockTitan · Jun 9 at 11:30 AM
Aldeyra Therapeutics Appoints Darlene Deptula-Hicks to Board of Directors | ALDX Stock News
